Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.

Autor: Jingru Yu, Refsum, Erle, Wieszczy, Paulina, Helsingen, Lise M., Perrin, Vera, Högdén, Amanda, Løberg, Magnus, Blom, Johannes, Bretthauer, Michael, Adami, Hans-Olov, Weimin Ye, Kalager, Mette

Publikováno v: BMJ Open Gastroenterology; 2023, Vol. 10 Issue 1, p1-9, 27p

Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.

Autor: Yu J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Refsum E; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway erle.refsum@medisin.uio.no.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway., Wieszczy P; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland., Helsingen LM; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway., Perrin V; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Högdén A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Løberg M; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway., Blom J; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Bretthauer M; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway., Adami HO; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway., Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology and Health Statistics & Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, P.R. China., Kalager M; Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.; Clinical Effectiveness Research Group, Institute of Health and Society, Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.

Publikováno v: BMJ open gastroenterology [BMJ Open Gastroenterol] 2023 May; Vol. 10 (1).